Mar 3, 2026 08:01AM
Mar 3, 2026 08:00AM
Feb 26, 2026 08:00AM
Feb 12, 2026 08:00AM
Jan 27, 2026 08:05AM
Jan 21, 2026 04:01PM
Jan 9, 2026 08:05AM Delcath Systems reports preliminary 2025 revenue of $85.2 million
Jan 9, 2026 08:05AM
Dec 31, 2025 08:00AM
Dec 31, 2025 08:00AM
Dec 3, 2025 04:11PM
Dec 3, 2025 04:01PM
Nov 20, 2025 04:01PM
Nov 20, 2025 04:01PM Delcath Systems Board of Directors Authorizes $25 Million Share Repurchase Program
Nov 18, 2025 08:00AM
Nov 14, 2025 04:01PM
Nov 13, 2025 08:32AM
Nov 13, 2025 08:30AM
Nov 6, 2025 04:01PM
Nov 4, 2025 08:00AM
Oct 21, 2025 08:30AM Delcath Systems to Host Third Quarter 2025 Earnings Call
Oct 20, 2025 07:52AM
Oct 20, 2025 07:51AM
Oct 18, 2025 04:15PM
Oct 18, 2025 04:13PM
Sep 22, 2025 04:01PM
Sep 22, 2025 04:01PM
Sep 5, 2025 04:01PM Delcath Systems, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Aug 21, 2025 08:30AM
Aug 19, 2025 08:30AM
Aug 19, 2025 08:30AM
Aug 6, 2025 08:00AM
Jul 29, 2025 04:01PM
Jul 25, 2025 04:01PM
Jul 23, 2025 04:01PM Delcath Systems to Host Second Quarter 2025 Earnings Call
May 22, 2025 07:01AM
May 22, 2025 07:00AM
May 15, 2025 04:30PM
May 9, 2025 05:30PM
May 8, 2025 07:30AM
Apr 28, 2025 08:31AM
Apr 28, 2025 08:30AM Delcath Systems Announces FDA Clearance of IND Application for Phase 2 Clinical Trial of HEPZATO™ in Liver-Dominant Metastatic Breast Cancer
Apr 24, 2025 04:01PM
Apr 9, 2025 05:00PM
Mar 27, 2025 04:45PM
Mar 27, 2025 04:45PM
Mar 24, 2025 04:01PM
Mar 14, 2025 04:02PM
Mar 14, 2025 04:01PM Delcath Systems, Inc. Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Mar 6, 2025 08:00AM

312,667 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All